Followers | 36 |
Posts | 2,689 |
Boards Moderated | 0 |
Alias Born | 06/09/2011 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Naked short volume over the past few weeks!
https://otcshortreport.com/company/NWBO
Date Close High Low Volume Short Volume % of Vol Shorted
Jun 07 NA NA NA 4,391,567 2,397,766 54.60
Jun 06 NA NA NA 3,038,136 1,324,631 43.60
Jun 05 NA NA NA 1,437,921 676,752 47.06
Jun 02 NA NA NA 975,052 495,035 50.77
Jun 01 NA NA NA 660,639 241,864 36.61
May 31 NA NA NA 1,084,589 472,807 43.59
May 30 NA NA NA 975,632 432,000 44.28
May 26 NA NA NA 1,013,957 474,493 46.80
May 25 NA NA NA 871,856 339,721 38.97
May 24 NA NA NA 1,461,516 622,345 42.58
May 23 NA NA NA 619,959 279,154 45.03
May 22 NA NA NA 1,005,717 411,055 40.87
May 19 NA NA NA 998,669 487,659 48.83
May 18 NA NA NA 1,027,114 427,200 41.59
May 17 NA NA NA 1,363,094 611,271 44.84
May 16 NA NA NA 1,623,373 710,077 43.74
May 15 NA NA NA 897,766 416,918 46.44
May 12 NA NA NA 1,719,863 1,177,752 68.48
May 11 NA NA NA 973,013 510,197 52.43
May 10 NA NA NA 2,402,352 1,239,819 51.61
May 09 NA NA NA 1,290,032 736,868 57.12
Dr. Shah, lead researcher on this study says it is still 3-5 years out from being available to patients. Covid vaccines granted approval within a year and cancer kills more people per month than covid. NWBO/DCVax-L news will be off the charts once they PR commercial manufacturing approval at Sawston in UK. Too many people dying every day from glioblastoma and recurrent glioblastoma as well as and solid tumor cancers! JMO!
https://www.boston25news.com/news/local/boston-researchers-testing-vaccine-deadly-brain-cancer/4FRW4YWUZ5GHHA7HESIDQ3NR6E/
Sojo so obvious this trading is being manipulated!! Disgusting human beings wanting to stop this from getting to patients. Just awful as people are dying from nGBM and rGBM needing this to prolong if not cure them. Always love your TA and charts!!
Love your technical analysis Sojo!! Have a great weekend!
This was in next section:
“Our allogeneic (donor cells) and autologous (patient’s own cells) comprehensive cell therapy manufacturing portfolio of services includes GMP production of cells from a variety of starting materials including immune cell populations (such as T-cells, NKs, Dendritic cells) and stem cells. Our experienced team is well-versed in supporting clients through the development pathway, optimizing development protocols, and securely and swiftly scaling up production from clinical to commercial scale.”
If NWBO comes out with peer reviewed publication Top Line PR this will go viral. Notice the language from the comments from the article below are in sync with what NWBO has publically stated with regards publication and peer review IMHO. NWBO needs to get this to patients ASAP!
We respond to “promising” survival data from phase III trial of DCVax®-L
We respond to preliminary overall survival data from phase III clinical trial that suggests DCVax-L may help extend survival for patients with newly-diagnosed or recurrent glioblastomas.
Thursday 26 May 2022
By Glenn Saitch
https://www.thebraintumourcharity.org/media-centre/news/research-news/we-respond-to-promising-survival-data-from-phase-iii-trial-of-dcvax-l/
Hi Basin, please add me to your zoom call list. Thank you!
Totally agree with you! Seen this many times before.
Sojourner55, look at the last 3.5 minutes of trades yesterday totally being suppressed with a 300 share sell into close at 3:59:56 and all the large buys leading up to it. All JMHO.
https://www.otcmarkets.com/stock/NWBO/quote
Standing ovation from me! Great post reachjo!
[quotereachjo
Member Level
Wednesday, April 20, 2022 10:04:46 PM
Re: jondoeuk post# 461274
Post#
461342
of 461748
I knew someone who was diagnosed with GBM in September 2020 and sent him everything we had on DCVax, even NWBO contacts, before he chose SOC. The decisions patients face with GBM are complex, painful and always end with loss. They are desperate for themselves, but even more so for the children, spouses, friends, etc…they will ultimately leave behind. There is no joy in those decisions, only necessity. I can’t say why he chose the path he did, but a small part of me thinks FUD impacted his decision regarding treatment. He died on March 30, 2022.
Posting FUD like that from an unqualified narcissist does nothing but ultimately hurt the patient. If you want to attack the business and legal side of NWBO have at it. I’m asking you as a fellow human being to please stay away from posting FUD on clinical efficacy while the jury is out. Realize that some people are reading this board for a very different reason than stock price. They are desperately searching for answers and are vulnerable to uninformed imposters, like AF, who make unsubstantiated scientific/medical claims. I know you have a job to do, but don’t be the person who stands in the way of a treatment that could save a loving father, husband, talented musician, ect…
Don’t be the reason the music stopped.][/quote]
Soj, totally agree AF shows up the desperation in the air right now, we are very close to major news....the shorts are trying to keep their nose above water right now. I love your charts along with Judge. Thanks to the many longs here too many to name for your contributions to this board. I rarely post anymore but do read this board often and have block all the fudsters.
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER
02/28/2022 22,051,004 9.92 2,149,027 10.26
02/15/2022 20,060,226 4.88 2,427,419 8.26
https://www.otcmarkets.com/stock/NWBO/quote
My condolences on your loss Gary and you and your family are in my prayers.
Found this interesting regarding Charles River Labs website feature on January 3, 2022 my highlights in BOLD: IMHO they are Manufacturing Ready for DCVax!
The promise offered by cell and gene therapies is currently tempered by the many challenges associated with developing them. Identifying a partner that can help guide, innovate, and navigate around them is a critical success factor for any program. Committed to this form of collaboration and support for our cell and gene therapy clients, we are pleased to announce the full integration of Cognate BioServices, Cobra Biologics, Vigene Biosciences, Hemacare, Cellero, Distributed Bio, Retrogenix into Charles River.
Today’s announcement marks another key milestone in our mission to invest in the tools, talent, and capacity to further the new frontier of regenerative medicine. With the benefit of a shared quality system, faster internal technical transfer, and process crossover between teams helping to reduce program bottlenecks and providing a seamless experience, we are now uniquely positioned to help our clients accelerate and achieve critical development goals from discovery to commercialization.
We have supported the development of 10 FDA-approved cell and gene therapies and have conducted more than 900 studies in this field over the past year. A key aim of this integration is to enhance client access to this wealth of scientific and regulatory experience as well as harnesses the power of our multidisciplinary bench of experts to problem solve in a collaborative manner every step of the way.
https://www.criver.com/insights/charles-river-integrates-cell-and-gene-therapy-acquisitions-enhance-end-end-offering-developers
ATLnsider, totally agree with you on your post!
Jack, long time NWBO shareholder here who rarely posts on here anymore but I do read this board daily with so many great contributors here minus all the posters on ignore. Totally agree with your post!
Interesting NVCR hit 52 week low today down 7% today…..hmmmm!
I saw that as well ATLnsider and caught my attention. Agree with you 100%!
Very well done alphapuppy! I appreciate you putting this together and I as well look forward to TLD and how close your analysis matches TLD for DCVax-L. Thank you again.
Greatr find reachjo! Great story on power of DCVax-L and this platform for all operable and inoperable solid tumors. Go NWBO!
Great post Flip very well done!
Great call yesterday Sojo!!
As of 10/14 at 6:30AM:
SHARES OUT
893,798,128
Biosect, NWBO would have never PR’d the MHRA inspection if their name was not associated with getting approval on the inspection certificate. JMHO
Very well said beachhyena!! I do not post on here often but long time long (2008) and thanks to so many outstanding posters on this board too many to list here that refute so many of the short theorist on here. GLTA Longa and patients and caregivers.
Great post!! I totally agree with you!
Great call on this Sojo! Love your TA!
Great find! Wow that is a lot of money!
My condolences on your loss and may the Lord comfort you and your family!
Great post Bright Boy and agree with you on this post!
Greats call Sojo!!! Love your charts and TA projections!
Great call Sojo! Looks like going to break $1.70 if this volume continues at this pace all day!
Nice open and buy volume !
Great post! Agree with you 100%!
Nice buying volume in last 20 minutes let’s see if it continues! GLTA!
$22 premarket! Wow bought in yesterday at $8.96!
Any news? 4.6M shares pre-market and $2.22 !